mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
about
Pharmacotherapy for stimulant-related disordersModulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addictionAldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical applicationChronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in miceMethylsulfonylmethane: Applications and Safety of a Novel Dietary SupplementPharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature.The interactome of the copper transporter ATP7A belongs to a network of neurodevelopmental and neurodegeneration factors.The Health Effect of Psychostimulants: A Literature ReviewEffects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys.The α1 Antagonist Doxazosin Alters the Behavioral Effects of Cocaine in RatsDisulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Mechanism-based inactivation of human CYP2E1 by diethyldithocarbamate.Gender differences in clinical outcomes for cocaine dependence: randomized clinical trials of behavioral therapy and disulfiram.Chronic loss of noradrenergic tone produces β-arrestin2-mediated cocaine hypersensitivity and alters cellular D2 responses in the nucleus accumbensDisulfiram efficacy in the treatment of alcohol dependence: a meta-analysis.Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.The effects of post-extinction exercise on cocaine-primed and stress-induced reinstatement of cocaine seeking in ratsInhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis.Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs-disulfiram and ritonavir.S-(N, N-diethylcarbamoyl)glutathione (carbamathione), a disulfiram metabolite and its effect on nucleus accumbens and prefrontal cortex dopamine, GABA, and glutamate: a microdialysis study.The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial.Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder.The selective dopamine β-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behaviorThe alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study.The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2- and Akt-dependent mechanism.Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviorsPharmacogenetics of alcohol, nicotine and drug addiction treatments.Current progress in pharmacologic treatment strategies for alcohol dependence.Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy.Norepinephrine regulates cocaine-primed reinstatement via α1-adrenergic receptors in the medial prefrontal cortex.Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore.Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex.α1b-Adrenergic Receptor Localization and Relationship to the D1-Dopamine Receptor in the Rat Nucleus Accumbens.Effects of disulfiram on choice behavior in a rodent gambling task: association with catecholamine levels.
P2860
Q26829186-876B5C96-9FF2-47D5-B954-37227964D89DQ27014154-BE35722C-756B-4542-A9D0-4E8F5CAB3836Q28265682-AFA999A5-384B-4443-9962-898E51E9041DQ28485338-86B54C6D-5800-466E-B4E2-E41C2C7C8D7FQ29247903-9CC9BB7B-24AA-4A35-88C3-EEFF90D5CBCBQ33582063-9E659AED-1282-4B94-A909-6FE5E8D02B23Q33591202-BEC8E0AE-E91C-4312-A37F-7A48007C8676Q33677986-4A417718-799B-4E65-A83F-05DF91A94FFDQ33750819-A763CD1C-53C4-4029-9EB6-D55D7531767DQ33771996-5185422C-4BC3-4985-A9D5-0EAA638EC2DEQ34205763-E15A3EFC-425C-4503-83C1-2D88937D9F78Q34253787-BDE50D42-CE49-4D68-A7BE-1F0A2E80FB77Q34359473-17FBC4C2-8FC3-4E03-96A8-48DC1306DAB8Q34717570-DDE1F200-BD7E-429B-9DA5-BE59193E4C66Q35079713-CBD969A1-7D55-45E2-B6EF-04D9BA053617Q35092623-01F89479-7874-4DD5-8485-0D1DD9D4D8DDQ35162034-57CB351A-2429-4742-88C3-82D9132342CEQ35305319-8F5EE3ED-F644-48A9-8C6E-A202CB2AA75FQ35320772-39C6D116-1F2F-40EB-B746-14D866D1CDFDQ36036175-6CA34912-B2F4-4C20-B24D-D856FE8E1511Q36121190-08E6A086-45FB-4CCB-AA46-E3BDE88E9093Q36243255-1BF074F8-92C4-45CD-AC5E-4FC3D5346AF9Q36384712-7D5F5106-1D59-49E2-80C7-5DF3CC8212FBQ36650526-A05F4AAC-B6C7-498A-A736-013336730DA6Q36775245-345A3A7D-4BAE-4C87-A0CD-631D26B739B9Q36847296-2AA8492D-A6E7-4345-A1DA-A256BF729E84Q36904042-1459C7F5-8792-42EB-8785-10E8022F8BF2Q37282486-130BCC08-8E23-405F-BB6A-643CBBFDA7BBQ37331807-09FA866A-1018-4BC0-815D-F83571957D63Q37616054-4BFB1413-FFB2-4723-A3BC-BE1D1F0F5063Q37663376-2C8B6148-77DE-44A4-9906-7848096BE2C0Q37848476-951FEBA6-F939-437A-BD0B-7F205D90429BQ38040129-D9AB947A-145E-45C4-8A05-0D149E1B7A6AQ38271498-8C6A3475-9644-45AD-BDE8-9C8EA3CFDE73Q38845514-A7E27FF8-0078-4F7A-8438-DFFDCD53D96DQ38916400-79B70414-EC4A-4E1F-8932-E40908067008Q39144955-8A419E44-89A1-4825-87A1-BF0454E91A77Q41832699-14B9C38B-7AE0-4C79-B9D1-60FB35C2E16EQ46097414-382D5616-CB00-46FA-BBDB-A66B0A2C1F54Q47585471-C57318C7-B60F-4860-96C7-46EA10DC7285
P2860
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@ast
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@en
type
label
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@ast
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@en
prefLabel
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@ast
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@en
P2860
P356
P1476
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse
@en
P2093
David Weinshenker
Meriem Gaval-Cruz
P2860
P304
P356
10.1124/MI.9.4.6
P577
2009-08-01T00:00:00Z